USSTOCK.TODAY
Pre-Market Log in Sign up

Zymerworks signs licensing agreement with Roche worth up to $813 million

Investing.com · ·by G4L

ZYME
ZYME Zymeworks BC Inc
$26.86 +3.15%
View chart & analysis →
  1. 1Zymerworks shares rose 5.5% during Friday pre-market trading.
  2. 2The company announced a deal that includes a $55 million upfront payment to Zymerworks.
  3. 3Roche will support Phase 1a clinical trials and manage subsequent global development and commercialization.

So what's the key point?

Zymerworks signed a large technology deal with Roche. The stock price rose because the deal includes a $55 million upfront payment.

Source Investing.com · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →